Neutrophil C5a receptor and the outcome in a rat model of sepsis
- 15 August 2003
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 17 (13), 1-17
- https://doi.org/10.1096/fj.03-0009fje
Abstract
Complement fragment 5a (C5a)-C5a receptor (C5aR) signaling plays an essential role in neutrophil innate immunity. Blockade of either the ligand or the receptor improves survival rates in experimental sepsis. In the current study, sepsis was induced in rats by cecal ligation/puncture. Early in sepsis C5aR content on neutrophils significantly dropped, reached the nadir at 24 h after onset of sepsis, and progressively elevated thereafter. Western-blot, RT-PCR, and confocal microscopy analyses revealed that the loss and re-expression of C5aR during sepsis might be due, at least in part, to the receptor internalization and reconstitution. The reduction and reconstitution of C5aR correlate with the loss and restoration of innate immune functions of blood neutrophils (chemotaxis and reactive oxygen species production), respectively. Quantitative measurements of C5aR on blood neutrophils are highly predictive of survival or death during sepsis. These data suggest that neutrophil C5aR content represents an essential component of an efficient defense system in sepsis and may serve as a prognostic marker for the outcome.Keywords
Funding Information
- National Institutes of Health (GM-61656, HL-31963)
- American Lung Association (RG-057-N)
This publication has 38 references indexed in Scilit:
- Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonistBritish Journal of Pharmacology, 2001
- Altered Expression of CD88 and Associated Impairment of Complement 5a–Induced Neutrophil Responses in Human Immunodeficiency Virus Type 1–Infected Patients with and without Pulmonary TuberculosisThe Journal of Infectious Diseases, 2001
- Protective effects of anti‐C5a peptide antibodies in experimental sepsisThe FASEB Journal, 2001
- Molecular Cloning and Characterization of a Novel Human CC Chemokine, SCYA26Genomics, 1999
- The C terminus of the human C5a receptor (CD88) is required for normal ligand‐dependent receptor internalizationEuropean Journal of Immunology, 1997
- The Human Chemoattractant Complement C5a Receptor Inhibits Cyclic AMP Accumulation Through Gi and Gz ProteinsBiochemical and Biophysical Research Communications, 1995
- POSTINJURY NEUTROPHIL PRIMING AND ACTIVATION STATESShock, 1995
- Decreased polymorphonuclear leukocyte exudation in critically ill anergic patients associated with increased adhesion receptor expressionCritical Care Medicine, 1993
- The systemic inflammatory response syndrome (SIRS): Immunology and potential immunotherapyInfection, 1993
- Different sensitivities of the responses of human neutrophils stimulated with immune complex and C5a anaphylatoxin to pertussis toxinFEBS Letters, 1988